Physician
D&J Grace Team LLC
D&J Grace Team LLC was paid $3.71M by Medicaid between Jan 2018 and Dec 2024, across 116 billing codes. Its largest line is 99091, — 34% of everything it billed.
33Billing provider infoD&J GRACE TEAM LLC
CROWLEY, TX 76036
CROWLEY, TX 76036
33aNPI1093062937assigned 08/09/2012
33bProvider typeFamily Medicine Physician
28Total paid$3.71M
24GClaims133,234
24DCodes billed116
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Texas
Rank by total paid#30 of 1,204
Median peer was paid$31K
This provider vs. median120×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,634 | $8K | |
| 2019 | 2,865 | $9K | |
| 2020 | 15,075 | $351K | |
| 2021 | 31,749 | $1.03M | |
| 2022 | 33,282 | $922K | |
| 2023 | 34,991 | $951K | |
| 2024incomplete | 13,638 | $438K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99091 | 34% | 8,181 | 7,926 | $1.26M | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 15,041 | 11,087 | $606K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 11% | 1,338 | 1,135 | $419K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.1% | 6,924 | 5,670 | $227K |
| 99423 | 3.9% | 2,825 | 840 | $144K | |
| 95923 | 3.2% | 1,553 | 1,399 | $120K | |
| 86328 | 3.0% | 3,090 | 2,668 | $113K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.4% | 2,756 | 2,529 | $51K |
| 92100 | 1.3% | 912 | 831 | $46K | |
| 80053 | Comprehensive metabolic panel | 1.1% | 6,311 | 5,164 | $43K |
| 93000 | 1.1% | 4,978 | 4,220 | $41K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.1% | 597 | 555 | $40K |
104 more codes
| 83880 | <1% | 1,134 | $28K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,489 | $28K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,442 | $27K |
| 83013 | <1% | 540 | $27K | |
| 80061 | Lipid panel | <1% | 2,975 | $25K |
| 84481 | <1% | 2,241 | $25K | |
| 93923 | <1% | 449 | $23K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,165 | $23K |
| 82670 | <1% | 1,147 | $23K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,537 | $22K |
| 84403 | <1% | 1,260 | $22K | |
| 83970 | <1% | 821 | $22K | |
| 83735 | <1% | 4,889 | $22K | |
| 82607 | <1% | 2,272 | $21K | |
| 87631 | <1% | 224 | $21K | |
| 94010 | <1% | 1,089 | $20K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 340 | $18K |
| 80050 | General health panel | <1% | 562 | $16K |
| 82746 | <1% | 1,461 | $14K | |
| 84439 | <1% | 2,293 | $14K | |
| 99385 | <1% | 170 | $10K | |
| 80305 | <1% | 1,110 | $10K | |
| 99386 | <1% | 140 | $10K | |
| 83540 | <1% | 1,916 | $8K | |
| 82553 | <1% | 1,088 | $8K | |
| 86140 | <1% | 2,095 | $7K | |
| 90756 | <1% | 371 | $7K | |
| 82043 | <1% | 1,743 | $7K | |
| 82150 | <1% | 1,302 | $6K | |
| 82570 | <1% | 1,514 | $5K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 217 | $5K |
| 84550 | <1% | 1,523 | $5K | |
| 82550 | <1% | 1,086 | $4K | |
| 86769 | <1% | 335 | $4K | |
| 81003 | <1% | 2,665 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 66 | $4K |
| 99490 | Ccm add 20min | <1% | 1,259 | $4K |
| 82533 | <1% | 320 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 110 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 359 | $3K |
| 83014 | <1% | 523 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 96 | $2K |
| 83690 | <1% | 443 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,037 | $2K |
| 84153 | <1% | 166 | $2K | |
| 82378 | <1% | 144 | $2K | |
| 92250 | <1% | 29 | $2K | |
| 85027 | <1% | 473 | $2K | |
| 86301 | <1% | 118 | $2K | |
| 0011A | <1% | 54 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 30 | $1K |
| 86803 | <1% | 123 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 27 | $1K |
| 0012A | <1% | 41 | $1K | |
| 80074 | <1% | 47 | $1K | |
| 86708 | <1% | 123 | $1K | |
| 86704 | <1% | 123 | $1K | |
| 86706 | <1% | 124 | $986.13 | |
| 87340 | <1% | 123 | $933.99 | |
| 87070 | <1% | 147 | $790.49 | |
| 86431 | <1% | 193 | $781.12 | |
| 87486 | <1% | 32 | $687.55 | |
| 86701 | <1% | 101 | $659.86 | |
| 87581 | <1% | 31 | $658.07 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 32 | $656.60 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,191 | $573.40 |
| 87252 | <1% | 29 | $569.40 | |
| 83605 | <1% | 82 | $563.76 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 101 | $556.30 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 47 | $551.73 |
| 99487 | Ccm add 20min | <1% | 110 | $406.54 |
| 84144 | <1% | 20 | $262.80 | |
| 83001 | <1% | 20 | $234.15 | |
| 83002 | <1% | 20 | $233.40 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 17 | $206.36 |
| 99442 | <1% | 304 | $179.82 | |
| 99374 | <1% | 15 | $176.26 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 173 | $159.23 |
| 86304 | <1% | 12 | $158.19 | |
| 99441 | <1% | 15 | $154.98 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 167 | $128.18 |
| 84484 | <1% | 14 | $83.76 | |
| 84480 | <1% | 208 | $71.46 | |
| 82044 | <1% | 16 | $41.84 | |
| 84436 | <1% | 208 | $34.62 | |
| 1159F | 0% | 1,396 | $0.00 | |
| 3078F | 0% | 399 | $0.00 | |
| 1160F | 0% | 1,396 | $0.00 | |
| 3077F | 0% | 153 | $0.00 | |
| 99497 | 0% | 12 | $0.00 | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 0% | 47 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 14 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 45 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 8,529 | $0.00 |
| 1111F | 0% | 573 | $0.00 | |
| 1125F | 0% | 1,306 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 16 | $0.00 |
| 3079F | 0% | 249 | $0.00 | |
| 96127 | 0% | 129 | $0.00 | |
| 3074F | 0% | 433 | $0.00 | |
| 3075F | 0% | 86 | $0.00 | |
| 3080F | 0% | 50 | $0.00 | |
| 96150 | 0% | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHANNA, EHAB (OWNER)